These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7657064)

  • 1. Toxicologic evaluations of an immunotoxin, H65-RTA.
    Kung AH; Cavagnaro JA; Makin A; White MA; Kong KN
    Fundam Appl Toxicol; 1995 Jun; 26(1):75-84. PubMed ID: 7657064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of H65-RTA immunoconjugate in patients with cutaneous T-cell lymphoma.
    LeMaistre CF; Rosen S; Frankel A; Kornfeld S; Saria E; Meneghetti C; Drajesk J; Fishwild D; Scannon P; Byers V
    Blood; 1991 Sep; 78(5):1173-82. PubMed ID: 1878584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the systemic toxicity and pharmacokinetics of the immunoconjugate anti-B4-blocked ricin in non-human primates. Delivered by multiple bolus injections and by continuous infusion.
    Shah SA; Lambert JM; Goldmacher VS; Esber HJ; Levin JL; Chungi V; Zutshi A; Braman GM; Ariniello PD; Taylor JA
    Int J Immunopharmacol; 1993 Aug; 15(6):723-36. PubMed ID: 7691767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity and efficacy of anti-T-cell ricin toxin A chain immunotoxins in a murine model of established graft-versus-host disease induced across the major histocompatibility barrier.
    Vallera DA; Carroll SF; Snover DC; Carlson GJ; Blazar BR
    Blood; 1991 Jan; 77(1):182-94. PubMed ID: 1984794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of an anti-CD5-ricin A chain immunoconjugate in an improved human peripheral blood lymphocyte--reconstituted severe combined immunodeficient mouse model.
    Kohn FR; Fishwild DM; Kung AH
    Int J Immunopharmacol; 1993 Aug; 15(6):695-709. PubMed ID: 7691766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I/II study of murine monoclonal antibody-ricin A chain (XOMAZYME-Mel) immunoconjugate plus cyclosporine A in patients with metastatic melanoma.
    Selvaggi K; Saria EA; Schwartz R; Vlock DR; Ackerman S; Wedel N; Kirkwood JM; Jones H; Ernstoff MS
    J Immunother Emphasis Tumor Immunol; 1993 Apr; 13(3):201-7. PubMed ID: 8471594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of cyclophosphamide on the toxicity and immunogenicity of ricin A chain immunotoxin in rats.
    Stoudemire JB; Mischak R; Foxall C; Harkonen WS; Del Rio M; Spitler LE
    Mol Biother; 1990 Sep; 2(3):179-84. PubMed ID: 2222902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and toxicology of immunotoxins administered into the subarachnoid space in nonhuman primates and rodents.
    Muraszko K; Sung C; Walbridge S; Greenfield L; Dedrick RL; Oldfield EH; Youle RJ
    Cancer Res; 1993 Aug; 53(16):3752-7. PubMed ID: 8339287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chronic lymphocytic leukemia antigen (cCLLa) as immunotherapy target: assessment of LD50 and MTD of four ricin-based anti-cCLLa immunotoxins (ITs) in Balb/c mice.
    Faguet GB; Agee JF
    Leuk Lymphoma; 1997 May; 25(5-6):531-7. PubMed ID: 9250824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of ricin B chain in the intracellular trafficking of anti-CD5 immunotoxins.
    Manske JM; Buchsbaum DJ; Vallera DA
    J Immunol; 1989 Mar; 142(5):1755-66. PubMed ID: 2465347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-pan T lymphocyte ricin A chain immunotoxin (H65-RTA) and methylprednisolone for acute GVHD prophylaxis following allogeneic BMT from HLA-identical sibling donors.
    Krance R; Heslop HE; Mahmoud H; Ribeiro R; Douglass E; Hurwitz C; Santana V; Kun L; Horowitz MM; Brenner MK
    Bone Marrow Transplant; 1993 Jan; 11(1):33-6. PubMed ID: 8431709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeys.
    Hertler AA; Schlossman DM; Borowitz MJ; Poplack DG; Frankel AE
    Cancer Immunol Immunother; 1989; 28(1):59-66. PubMed ID: 2783301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of intrathecal transferrin-ricin a chain immunotoxin.
    Candiani C; Tommasi M; Fracasso G; Lorenzetti I; Adami A; Benoni G; Tridente G; Colombatti M
    Life Sci; 2001 Jun; 69(3):335-46. PubMed ID: 11441924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity of ricin toxin A chain in rats.
    Alipour M; Pucaj K; Smith MG; Suntres ZE
    Drug Chem Toxicol; 2013 Apr; 36(2):224-30. PubMed ID: 22947129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of an anti-pan T-lymphocyte ricin a chain immunotoxin in steroid-resistant acute graft-versus-host disease.
    Byers VS; Henslee PJ; Kernan NA; Blazar BR; Gingrich R; Phillips GL; LeMaistre CF; Gilliland G; Antin JH; Martin P
    Blood; 1990 Apr; 75(7):1426-32. PubMed ID: 2180494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer.
    Byers VS; Rodvien R; Grant K; Durrant LG; Hudson KH; Baldwin RW; Scannon PJ
    Cancer Res; 1989 Nov; 49(21):6153-60. PubMed ID: 2790828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation and prevention of artifactual staining in flow cytometric analyses of whole blood samples from patients treated with H65-RTA, an anti-CD5 monoclonal antibody conjugated to ricin A chain.
    Fishwild DM; Saria EA
    J Immunol Methods; 1991 Nov; 144(1):27-34. PubMed ID: 1720441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of antibody responses to ricin A chain (RTA) by monoclonal anti-RTA antibodies.
    Byers VS; Austin EB; Clegg JA; Denton G; Gunn B; Hooi D; Hudecz F; Price MR; Baldwin RW
    J Clin Immunol; 1993 Nov; 13(6):406-14. PubMed ID: 7507127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between in vivo toxicity and preclinical in vitro parameters for the immunotoxin anti-B4-blocked ricin.
    Grossbard ML; Lambert JM; Goldmacher VS; Blättler WA; Nadler LM
    Cancer Res; 1992 Aug; 52(15):4200-7. PubMed ID: 1379121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity and immunogenicity of monoclonal antimelanoma antibody-ricin A chain immunotoxin in rats.
    Harkonen S; Stoudemire J; Mischak R; Spitler LE; Lopez H; Scannon P
    Cancer Res; 1987 Mar; 47(5):1377-82. PubMed ID: 3493064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.